Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/33145
Title: Evaluation of Primary Resistance to HIV Entry Inhibitors Among Brazilian Patients Failing Reverse Transcriptase/Protease Inhibitors Treatment Reveal High Prevalence of Maraviroc Resistance-Related Mutations
Authors: Alencar, Cecilia S. [UNIFESP]
Nishiya, Anna S.
Ferreira, Suzete
Giret, Maria Teresa M.
Diaz, Ricardo S. [UNIFESP]
Sabino, Ester C.
Fundacao Prosangue
Universidade Federal de São Paulo (UNIFESP)
Universidade de São Paulo (USP)
Issue Date: 1-Dec-2010
Publisher: Mary Ann Liebert Inc
Citation: Aids Research and Human Retroviruses. New Rochelle: Mary Ann Liebert Inc, v. 26, n. 12, p. 1267-1271, 2010.
Abstract: Entry inhibitor is a new class of drugs that target the viral envelope protein. This region is variable; hence resistance to these drugs may be present before treatment. the aim of this study was to analyze the frequency of patients failing treatment with transcriptase reverse and protease inhibitors that would respond to the entry inhibitors Enfuvirtide, Maraviroc, and BMS-806. the study included 100 HIV-1 positive patients from one outpatient clinic in the city of São Paulo, for whom a genotype test was requested due to treatment failure. Proviral DNA was amplified and sequenced for regions of gp120 and gp41. A total of 80 could be sequenced and from those, 73 (91.3%), 5 (6.3%) and 2 (2.5%) were classified as subtype B, F, and recombinants (B/F and B/C), respectively. CXCR4 co-receptor use was predicted in 30% of the strains. Primary resistance to Enfuvirtide was found in 1.3%, following the AIDS Society consensus list, and 10% would be considered resistant if a broader criterion was used. Resistance to BMS-806 was higher; 6 (7.5%), and was associated to non-B strains. Strikingly, 27.5% of samples harbored one or more mutation among A316T, I323V, and S405A, which have been related to decreased susceptibility of Maraviroc; 15% of them among viruses predictive to be R5. A more common mutation was A316T, which was associated to the Brazilian B strain harboring the GWGR motif at the tip of V3 loop and their derivative sequences. These results may be impact guidelines for genotype testing and treatment in Brazil.
URI: http://repositorio.unifesp.br/handle/11600/33145
ISSN: 0889-2229
Other Identifiers: http://dx.doi.org/10.1089/aid.2010.0057
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.